NURSING STANDARD
FOLLOWING AN assessment of the patient's motivation to give up smoking, the next stage in the cessation process is to assist them to choose an appropriate intervention. This article provides practical information and advice when recommending nicotine replacement therapy (NRT), one of the original first-line treatments to help wean people off smoking tobacco.
Nicotine gum was first developed in the 1960s for use by those who were restricted from smoking in enclosed environments, for example, submariners (Munafo et al 2003) . NRT has been in clinical use since the 1980s and has been scrutinised extensively particularly in relation to efficacy and cost-effectiveness (Tengs et al 1995 , Silagy et al 2007 .
Nicotine replacement therapy
NRT became available on NHS prescription from April 2001 and continues to be the most popular first-line therapy. The supply of NRT on prescription has been widely campaigned for by public health groups and is known to double the chances of someone giving up smoking when used correctly (Raw et al 1998) . In 2002, NRT was given approval by the National Institute for Clinical Excellence (NICE) (2002) . There are six products licensed and available on prescription and over the counter.
NRT describes a group of products that deliver nicotine and are licensed for the relief of withdrawal symptoms as an aid to smoking cessation (McNeill et al 2001) . They provide controlled levels of nicotine release without smokers being exposed to chemicals, many of which are carcinogenic, via the inhalation of tobacco smoke. NRT delivers nicotine 'cleanly' and, therefore, is a safe product for the majority of smokers, and is less harmful than the risks associated with smoking (McNeill et al 2001) .
NRT products are much safer than cigarettes, which have been described as 'dirty' delivery systems for nicotine (Royal College of Physicians 2000) . It is the tobacco, not the nicotine, which causes most of the harm. It is estimated that there are more than 50 illnesses that are attributed to smoking tobacco, including cancer and vascular diseases. Fifty per cent of smokers will eventually be killed by their habit and around 114,000 people die as a result of tobacco use in the UK each year (Action on Smoking and Health 2007) .
Personal preference and common sense usually determine what type of NRT to choose. The overall efficacy of products does not differ widely and they have been shown to increase the odds of successful cessation 1.5 to 2 fold regardless of setting (Silagy et al 2007) . However, NRT has maximum effectiveness when used as part of a behavioural support package. The cost effectiveness of NRT has also been demonstrated in comparison to NHS norms and other treatments (NICE 2002) .
Sitting with the patient and talking through the advantages and disadvantages of each therapy provides a valuable opportunity to build rapport and to educate. It is generally accepted that the first one-to-one cessation session should be around 30 minutes. However, ensuring that the patient has been given some written information at the first point of contact, or at the 'ask' stagefor example, reception staff welcoming patients to the surgery for the first time before the smoking 
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This is the second of two articles on smoking cessation. It provides advice on helping a patient to choose an appropriate nicotine replacement therapy product.
cessation appointment -is a useful strategy. This can empower the patient to make an informed choice and allow trained healthcare professionals more time to discuss other important concerns that patients may want to clarify before they attempt to quit. Long-term quit rates are improved in those receiving additional support in the form of self-help material, for example, booklets and helplines (Fiore 1996) .
In attempting to match the correct dose and form of NRT for the individual patient, assessment of addiction is necessary. For example, finding out the number of cigarettes smoked daily and the time between waking and the first cigarette smoked can be combined to assess the level of addiction (West 2004) ( Table 1) . NRT patches These tend to be the most popular form of NRT. They are easy to use and release a steady dose of nicotine transdermally into the bloodstream over either 16 or 24 hours. They are licensed for those smoking ten cigarettes or more daily, however, there is no reason why those smoking less than ten cigarettes daily will not benefit (NICE 2002) .
The 24-hour patch is available in 7, 14 and 21mg doses and the 16mg patch is available in 5, 10 and 15mg preparations. The choice of patch depends on the patient's addiction. The 16-hour patch is indicated for those smoking more than ten cigarettes daily, however, there is no reason why lighter smokers cannot be offered them. Light smokers can be recommended to start on lower strength patches for a shorter period of time (British National Formulary (BNF) 2007).
Both the above regimens are effective, however, the 16-hour patch causes less sleep disturbance and less skin irritation. One patch should be applied each morning to dry, non-hairy skin on the trunk or upper arm. It should be removed at bedtime and a replacement should be applied using a different site the following morning. The 24-hour patch is particularly useful for those with early morning cravings. The same instructions apply to directions for use as the 16-hour patch, the only difference being that these patches should be removed and immediately reapplied 24 hours later (BNF 2007) .
Side effects, which may resemble withdrawal symptoms, include: nausea, palpitations, vivid dreams and dizziness. Specific side effects for patches are skin irritation. If patients experience excessive side effects, which do not resolve within a few days, then stepping down to the lower strength patch or changing the brand should be considered. NRT inhalator The nicotine inhalator resembles a plastic cigarette holder with a flat tip. They can draw unnecessary attention to the user, particularly in public places, however, they are particularly useful in those smokers who find it difficult to break the hand to mouth action associated with cigarette smoking.
The frequency of use depends on the previous smoking habit of the individual and should be used when the urge to smoke is felt. Patients are instructed to use a maximum of 12 cartridges per day for up to eight weeks, with an aim of reducing the number used to zero by the last day. Courses of 12 weeks are usually recommended, however, patients can have longer courses if required. A cartridge is inserted into the inhalator and can be puffed continuously for 20 minute periods for up to one hour in total (BNF 2007) .
Nicotine vapour is absorbed through the mouth by the buccal mucosa and requires greater inhalation effort than with a cigarette, therefore patients with chronic obstructive pulmonary disease may find them difficult to use. The most frequently reported side effects include cough, headache and oral, pharyngeal irritation. Patients Patients should be instructed to chew the gum whenever there is an urge to smoke using the 'chew and rest' technique. Directions for use should be to chew the piece of gum until the taste becomes strong then the piece of gum should be rested between the gum and cheek to allow absorption via the buccal mucosa. Each piece of gum normally lasts around 30 minutes. Any swallowed nicotine gum is destroyed by the liver.
Nicotine gum allows easy dose regulation and can stop overeating. Side effects include aphthous ulceration, throat irritation and cough. Possible problems also include gum sticking to dentures and jaw and tooth trouble. Patients requesting gum should be advised to keep dentures clean and well fitted. Patients' technique should be reviewed to ensure that the correct chewing action is used. Sublingual tablets (Nicorette ® Microtab) This tablet is used sublingually with a recommended dose of one tablet per hour, which can be increased to two per hour in those smoking more than 20 cigarettes per day. Most smokers require 8-12 or 16-24 tablets per day, but they should not exceed 40 tablets daily. Duration of treatment is usually around three months. Over that period patients should be advised to reduce their use gradually and treatment stopped when the daily consumption is down to one or two tablets per day (BNF 2007) .
The sublingual tablet can be used discreetly, has few side effects and the dose can be easily adjusted to suit the individual. Side effects can include heartburn, mouth irritation and hiccups. However, these tend to be transient and usually occur at the beginning of treatment. Therefore, patients should be encouraged to continue with the treatment. Nasal sprays The nicotine spray gives fast relief of withdrawal and may be particularly useful to heavy smokers. Each spray delivers 0.5mg of nicotine, about half of which is absorbed. The daily limit is 64 sprays, which is the equivalent of two sprays in each nostril every hour for 16 hours. The suggested course lasts three months with the aim of decreasing until the use of sprays finally ceases. The most common side effects include nasal irritation, watering eyes and throat irritation, however, these normally decline within the first few days of treatment (BNF 2007) . Lozenges The nicotine lozenge comes in 1mg, 2mg and 4mg strengths depending on the patient's nicotine dependence and doses can be easily adjusted. During the first six weeks of treatment, patients should be recommended to suck a minimum of nine lozenges daily and not to exceed 15 in 24 hours for the 2mg and 4mg doses. The 1mg dose should be taken every one to two hours not exceeding a maximum daily dose of 25 lozenges. Lozenges are discreet and easy to use and treatment should continue for around three months and usage should be reduced gradually and discontinued when using one or two lozenges per day (BNF 2007) .
Patients should be instructed to place one lozenge in the mouth and suck until the taste becomes strong. It should be moved from one side of the mouth to the other and allowed to dissolve for approximately 20-30 minutes. It is important to ensure that patients understand that they should not chew or swallow it whole and should not eat or drink at the same time as having a lozenge in the mouth.
Most side effects generally occur in the first four weeks of therapy and may include irritation of the throat, hiccups and heartburn (BNF 2007) . Advising patients to suck slower can overcome this problem.
Refer to an up-to-date BNF which is also available online at www.bnf.org.uk for information on all NRT products listed in this article.
Product licensing
Product licensing has been relaxed to include adolescents over 12 years old and those who are pregnant or at high vascular disease risk, with the key message that continued smoking far outweighs any risk from NRT (Duff 2005). Nicotine-assisted replacements (NARS) or Cut Down to Quit (CDTQ) allow combinations of NRT to be used together, usually a patch plus an oral product (for example, gum and inhalator). This allows smokers more freedom to tailor treatment regimens to suit their requirements (Medicines and Healthcare products Regulatory Agency and Committee on Safety of Medicines, NICE 2007). Local patient group directions (PGDs) or local NHS smoking cessation advisers can offer guidance on how patients can access second NRT products.
The Department of Health has agreed with major pharmaceutical companies to provide additional smoking cessation products free so helping the NHS stop smoking services to meet targets. One such scheme in Birmingham -Call to Quit -is offering a free stop smoking service where people with difficulty accessing services can be posted NRT depending on demography and local primary care trust arrangements. For more information on this service contact Call to Quit online at www.calltoquit.co.uk or freephone 0800 0525855.
Conclusion
Following the recent smoking ban making virtually all enclosed public places and workplaces in England smoke free, nurses trained in smoking cessation could improve their services to local people by collaborating with other service providers, such as local businesses and other agencies, educational and religious organisations. This would help to make cessation services more accessible and flexible in an everincreasing consumer-led market.
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